Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Cantor Fitzgerald
Deloitte
Cerilliant
Julphar
Covington
Chinese Patent Office
McKinsey

Generated: May 27, 2018

DrugPatentWatch Database Preview

Lansoprazole - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for lansoprazole and what is the scope of lansoprazole freedom to operate?

Lansoprazole
is the generic ingredient in seven branded drugs marketed by Ajanta Pharma Ltd, Dr Reddys Labs Ltd, Inventia Hlthcare, Krka Tovarna Zdravil, Labs Liconsa, Lannett Co Inc, Mylan Pharms Inc, Natco Pharma Ltd, Perrigo R And D, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, Wockhardt Ltd, Wockhardt Usa, Zydus Hlthcare, Takeda Pharms Usa, Glaxosmithkline Cons, Takeda Pharms Na, Ani Pharms Inc, Dexcel Pharma, and Teva Pharms Usa, and is included in twenty-nine NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lansoprazole has seventy-two patent family members in nineteen countries.

There are fifty-six drug master file entries for lansoprazole. Eighty-four suppliers are listed for this compound.
Pharmacology for lansoprazole
Medical Subject Heading (MeSH) Categories for lansoprazole
Synonyms for lansoprazole
(+)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
103577-45-3
1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-
1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
2-?[[[3-?METHYL-?4-?(2,?2,?2-?TRIFLUOROETHOXY)-?2-?PYRIDINYL]METHYL]SULFINYL]-?1H-?BENZIMIDAZOLE
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfinyl)benzimidazol e
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole;2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[ [3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl]methyl]-sulfinyl]1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylsulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole
2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzimidazole
2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole
2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl]-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl]-1H-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl]-1H-benzimidazole
2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole
2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl}-1H-benzimidazole
577L453
A 65006
A-65006
A800764
AB0005100
AB00052388
AB00052388_18
AB00052388_19
AB00052388-17
AB2000063
Abbot Brand of Lansoprazole
ABT-006
AC1L1GX8
ACT03358
AG 1749
AG-1749
Agopton
Agopton (TN)
AKOS005554811
Almirall Brand of Lansoprazole
AN-15125
API0005388
Aprazol
Bamalite
BBL029072
BC208317
BDBM47032
BDBM50070208
BG0232
BIDD:GT0006
Bio-0824
Biuret Gr
Biuret Reagent Solution
Blason
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
C-21097
C16H14F3N3O2S
CAS-103577-45-3
CC-29843
CCG-39952
CG-4801
CHEBI:6375
CHEMBL480
cid_3883
CL0035
Compraz
CPD000058469
CS-1847
CTK8F0500
D00355
D0M4HV
Dakar
DB00448
DivK1c_000920
DR002018
DSSTox_CID_3200
DSSTox_GSID_23200
DSSTox_RID_76922
DTXSID4023200
EBD14854
EU-0100709
F2173-0222
FT-0082011
FT-0610894
GP5308
GTPL7208
HE130807
HE291353
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS2098G06
HMS2234B10
HMS3262M19
HMS3264E12
HMS3269D15
HMS3371E21
HMS3394F05
HMS3654J17
HMS502N22
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
HSDB 7204
HY-13662
I06-0018
IDI1_000920
Ilsatec
J-007154
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
KS-00000VHO
L 8533
L0233
Lancid
Lanfast
Lanproton
LANSAPRAZOLE
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole (JAN/USP/INN)
Lansoprazole (JP17/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard
Lansoprazole, >=98% (TLC), powder
Lansoprazole, 98% 500mg
Lansoprazole, British Pharmacopoeia (BP) Reference Standard
Lansoprazole, European Pharmacopoeia (EP) Reference Standard
Lansoprazole, United States Pharmacopeia (USP) Reference Standard
Lansoprazole.
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lansox (TN)
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
lanzoprazole
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Lopac-L-8533
Lopac0_000709
LP00709
LS-33080
MCULE-8446262134
Mesactol
MFCD00866873
MJIHNNLFOKEZEW-UHFFFAOYSA-N
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
MLS001424235
MolPort-003-666-508
Monolitum
NC00411
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-04
NCGC00015615-05
NCGC00015615-06
NCGC00015615-07
NCGC00015615-08
NCGC00015615-09
NCGC00015615-10
NCGC00015615-11
NCGC00015615-12
NCGC00015615-14
NCGC00015615-15
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NCGC00254925-01
NCGC00261394-01
NINDS_000920
NSC-758638
NSC-758710
NSC758638
NSC758710
Ogast
Ogast (TN)
Ogastro
Opera_ID_1676
Opiren
Pharmakon1600-01503926
Pharmakon1600-01504282
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
Prevacid
Prevacid (TN)
Prevacid 24HR
Prevacid Delayed Release
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid NapraPAC
Prevacid SoluTab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevacid;Prevacid NapraPAC;Prevacid SoluTab
PrevOnco
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
PubChem16834
RT-013461
s1354
Salvar Brand of Lansoprazole
SAM001246544
SBI-0050687.P003
SC-15158
SCHEMBL22365
SMR000058469
SPBio_000488
SPBio_002992
Spectrum_001580
SPECTRUM1503926
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
ST51015040
STK621169
Suprecid
TAK 390MR
TAK390MR
Takeda Brand of Lansoprazole
Takepron
Takepron (TN)
TAP Brand of Lansoprazole
Tecnobio Brand of Lansoprazole
TL8000155
Tox21_110184
Tox21_110184_1
Tox21_301023
Tox21_500709
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton

US Patents and Regulatory Information for lansoprazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 090331-002 Apr 23, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa PREVACID lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 020406-001 May 10, 1995 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 202637-001 Sep 13, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wockhardt Usa LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 202176-002 Sep 14, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for lansoprazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Na PREVACID IV lansoprazole INJECTABLE;INTRAVENOUS 021566-001 May 27, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa PREVACID lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 020406-001 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa PREVACID lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 020406-001 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for lansoprazole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,070,805 Rapidly disintegrable solid preparation ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for lansoprazole

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
14/008 Ireland ➤ Try a Free Trial PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
C0021 Belgium ➤ Try a Free Trial PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0021 Belgium ➤ Try a Free Trial PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Farmers Insurance
Julphar
Teva
Merck
Boehringer Ingelheim
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.